Predicting counterfactual risks under hypothetical treatment strategies: an application to HIV.
Dickerman BA, Dahabreh IJ, Cantos KV, Logan RW, Lodi S, Rentsch CT, Justice AC, Hernán MA.
Eur J Epidemiol. 2022 Feb 22. PMID: 35190946
Instructors
Barbra Dickerman
Links
Bibliography
Comparative Effectiveness of BNT162b2 and mRNA-1273 Vaccines in U.S. Veterans.
Dickerman BA, Gerlovin H, Madenci AL, Kurgansky KE, Ferolito BR, Figueroa Muñiz MJ, Gagnon DR, Gaziano JM, Cho K, Casas JP, Hernán MA.
N Engl J Med. 2022 01 13. 386(2):105-115. PMID: 34942066
Estimating the effect of nutritional interventions using observational data: the American Heart Association's 2020 Dietary Goals and mortality.
Chiu YH, Chavarro JE, Dickerman BA, Manson JE, Mukamal KJ, Rexrode KM, Rimm EB, Hernán MA.
Am J Clin Nutr. 2021 08 02. 114(2):690-703. PMID: 34041538
Association of Prediagnostic Blood Metabolomics with Prostate Cancer Defined by ERG or PTEN Molecular Subtypes.
Feng X, Zhou CK, Clish CB, Wilson KM, Pernar CH, Dickerman BA, Loda M, Finn SP, Penney KL, Schmidt DR, Vander Heiden MG, Giovannucci EL, Ebot EM, Mucci LA.
Cancer Epidemiol Biomarkers Prev. 2021 05. 30(5):1000-1008. PMID: 33627383
Emulating a target trial in case-control designs: an application to statins and colorectal cancer.
Dickerman BA, García-Albéniz X, Logan RW, Denaxas S, Hernán MA.
Int J Epidemiol. 2020 10 01. 49(5):1637-1646. PMID: 32989456
Counterfactual prediction is not only for causal inference.
Dickerman BA, Hernán MA.
Eur J Epidemiol. 2020 Jul. 35(7):615-617. PMID: 32623620
A Metabolomics Analysis of Adiposity and Advanced Prostate Cancer Risk in the Health Professionals Follow-Up Study.
Dickerman BA, Ebot EM, Healy BC, Wilson KM, Eliassen AH, Ascherio A, Pernar CH, Zeleznik OA, Vander Heiden MG, Clish CB, Giovannucci E, Mucci LA.
Metabolites. 2020 Mar 10. 10(3). PMID: 32164144
Obesity, height, and advanced prostate cancer: extending current evidence toward precision prevention.
Dickerman BA, Mucci LA.
Ann Oncol. 2020 01. 31(1):7-8. PMID: 31912798
Risk of dementia following androgen deprivation therapy for treatment of prostate cancer.
Krasnova A, Epstein M, Marchese M, Dickerman BA, Cole AP, Lipsitz SR, Nguyen PL, Kibel AS, Choueiri TK, Basaria S, Mucci LA, Sun M, Trinh QD.
Prostate Cancer Prostatic Dis. 2020 09. 23(3):410-418. PMID: 31784699
Avoidable flaws in observational analyses: an application to statins and cancer.
Dickerman BA, García-Albéniz X, Logan RW, Denaxas S, Hernán MA.
Nat Med. 2019 10. 25(10):1601-1606. PMID: 31591592